Cooke & Bieler LP acquired a new stake in shares of Hill-Rom Holdings Inc. (NYSE:HRC) during the second quarter, Holdings Channel reports. The institutional investor acquired 298,020 shares of the medical technology company’s stock, valued at approximately $15,035,000.
Other large investors have also recently bought and sold shares of the company. Clark Capital Management Group Inc. increased its stake in shares of Hill-Rom Holdings by 36.9% in the first quarter. Clark Capital Management Group Inc. now owns 20,637 shares of the medical technology company’s stock valued at $1,038,000 after buying an additional 5,560 shares during the period. Prudential PLC increased its stake in shares of Hill-Rom Holdings by 7.2% in the first quarter. Prudential PLC now owns 377,110 shares of the medical technology company’s stock valued at $18,969,000 after buying an additional 25,400 shares during the period. Geode Capital Management LLC increased its stake in shares of Hill-Rom Holdings by 3.4% in the first quarter. Geode Capital Management LLC now owns 357,514 shares of the medical technology company’s stock valued at $17,982,000 after buying an additional 11,790 shares during the period. Goldman Sachs Group Inc. increased its stake in shares of Hill-Rom Holdings by 51.8% in the first quarter. Goldman Sachs Group Inc. now owns 337,464 shares of the medical technology company’s stock valued at $16,975,000 after buying an additional 115,170 shares during the period. Finally, AXA increased its stake in shares of Hill-Rom Holdings by 13,543.5% in the first quarter. AXA now owns 313,800 shares of the medical technology company’s stock valued at $15,784,000 after buying an additional 311,500 shares during the period. Hedge funds and other institutional investors own 83.16% of the company’s stock.
Hill-Rom Holdings Inc. (NYSE:HRC) traded up 0.91% on Tuesday, hitting $60.08. The stock had a trading volume of 178,921 shares. Hill-Rom Holdings Inc. has a 12-month low of $42.99 and a 12-month high of $63.12. The company’s 50 day moving average is $60.20 and its 200 day moving average is $53.96. The firm has a market cap of $3.93 billion, a PE ratio of 61.87 and a beta of 1.14.
Hill-Rom Holdings (NYSE:HRC) last issued its earnings results on Thursday, August 4th. The medical technology company reported $0.81 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.05. Hill-Rom Holdings had a return on equity of 16.62% and a net margin of 2.47%. The firm had revenue of $655.40 million for the quarter, compared to analysts’ expectations of $647.75 million. During the same quarter last year, the firm earned $0.62 earnings per share. The firm’s revenue for the quarter was up 38.1% compared to the same quarter last year. On average, equities research analysts expect that Hill-Rom Holdings Inc. will post $3.33 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, September 30th. Investors of record on Friday, September 16th were issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date was Wednesday, September 14th. Hill-Rom Holdings’s payout ratio is currently 73.91%.
Several equities research analysts have weighed in on HRC shares. Zacks Investment Research upgraded Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a report on Wednesday, September 21st. KeyCorp restated a “buy” rating and set a $59.00 price target on shares of Hill-Rom Holdings in a report on Thursday, June 23rd. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Hill-Rom Holdings currently has a consensus rating of “Buy” and an average price target of $62.20.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc. (NYSE:HRC).
Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.